Dominari Holdings Logo
US0088753043
A3DMBK
DOMH

Dominari Holdings

A carregar cotações...

Previsão

Comprar
  1
Manter
  0
Vender
  0

  • Dominari Holdings changes terms for Series A warrants and offers reduced exercise price

    Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » Mais em de.investing.com


  • Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity

    Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » Mais em de.investing.com


  • Dominari Holdings announces $10 million special dividend

    Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » Mais em de.investing.com

Em 2026, Dominari Holdings já distribuiu € 1,01 em dividendos. A última distribuição ocorreu em maio.

Dados financeiros da empresa

No último trimestre, Dominari Holdings registou receitas de € 14,71 mi e um ganho líquido de -€ 4,36 mi
(EUR) junho de 2026
YoY
Receitas 14,71 mi 49,15%
Ganho bruto 14,71 mi 49,15%
Ganho líquido -4,36 mi 130,96%
EBITDA -2,05 mi 87,45%

Dados fundamentais

Métrica Valor
Capitalização bolsista
€ 37,38 mi
Número de ações
24,24 mi
Máximo/mínimo de 52 semanas
€ 5,48 - € 1,53
Rentabilidade de dividendos
65,36%
Dividendos TTM
€ 1,01
Beta
0,88
PER (PE Ratio)
-0,49
PEG (PEG Ratio)
0,00
P/VC (PB Ratio)
1,80
P/V (PS Ratio)
0,31

Perfil da empresa

A Dominari Holdings Inc., uma empresa de biotecnologia, dedica-se ao desenvolvimento de terapêuticas anticancerígenas de moléculas pequenas. O portefólio de terapêuticas da empresa inclui terapias para o cancro da próstata, o cancro do pâncreas, a leucemia mieloide aguda (LMA) e a leucemia linfoblástica aguda. A empresa está a desenvolver o DHA-dFdC, um candidato a medicamento para o cancro do pâncreas; e o KPC34, um tratamento de moléculas pequenas para a leucemia mieloide aguda e a leucemia linfoblástica aguda. A empresa está também a desenvolver uma plataforma antiviral que inibe a replicação de vírus, incluindo o vírus da gripe, o Ebolavírus e o vírus de Marburg, o SARS-CoV, o MERS-CoV e o SARS-CoV-2. Tem acordos de licença com a University of Texas, a University of Maryland Baltimore, a Silo Pharma Inc. e a Wake Forest University Health Sciences. A empresa era anteriormente conhecida como AIkido Pharma Inc. e mudou o seu nome para Dominari Holdings Inc. em dezembro de 2022. A Dominari Holdings Inc. foi fundada em 1967 e tem sede em Nova Iorque, Nova Iorque.

Nome
Dominari Holdings
CEO
Anthony C. Hayes
Sede New York City, ny
EUA
Site
Setor
Finanças
Indústria
Serviços financeiros
Entrada em bolsa
18/03/1980
Colaboradores 36

Análise aprofundada

Símbolos de ticker

Bolsa Símbolo
NASDAQ
DOMH
Frankfurt
BP2A.F
Düsseldorf
BP2A.DU
🍪

Parqet  utiliza cookies. Saber mais